Real-World Experiences with Taliglucerase Alfa Home Infusions for Patients with Gaucher Disease: A Global Cohort Study

Taliglucerase alfa is an enzyme replacement therapy approved for Gaucher disease. We assessed the duration/compliance/safety of such home infusions in commercial use in four countries where home infusion programs are available. The treatment duration/compliance study included 173 patients (Israel, 5...

Descripción completa

Detalles Bibliográficos
Autores principales: Revel-Vilk, Shoshana, Mansfield, Royston, Feder-Krengel, Neta, Machtiger-Azoulay, Noya, Kuter, David, Szer, Jeff, Rosenbaum, Hanna, Ferreira, David Cavalcanti, Ruhrman-Shahar, Noa, Wajnrajch, Michael, Zimran, Ari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531841/
https://www.ncbi.nlm.nih.gov/pubmed/37762854
http://dx.doi.org/10.3390/jcm12185913

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10531841/
https://www.ncbi.nlm.nih.gov/pubmed/37762854
http://dx.doi.org/10.3390/jcm12185913

Ejemplares similares